AlphaCentric Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$394K Buy
1,865
+566
+44% +$122K 0.39% 89
2025
Q4
$267K Buy
+1,299
New +$244K 0.27% 122
2024
Q4
$66.7K Sell
564
-96
-15% -$11.2K 0.07% 185
2024
Q3
$72.9K Sell
660
-15
-2% -$1.57K 0.05% 208
2024
Q2
$66.4K Sell
675
-3,871
-85% -$394K 0.05% 196
2024
Q1
$509K Sell
4,546
-507
-10% -$54.7K 0.31% 82
2023
Q4
$509K Buy
5,053
+218
+5% +$21.6K 0.34% 70
2023
Q3
$420K Sell
4,835
-382
-7% -$34.5K 0.24% 94
2023
Q2
$493K Buy
+5,217
New +$441K 0.27% 97
2020
Q4
Sell
-6,714
Closed -$315K 209
2020
Q3
$315K Sell
6,714
-459
-6% -$23.6K 0.15% 27
2020
Q2
$374K Buy
+7,173
New +$370K 0.21% 24

Other funds holding CAH

AlphaCentric Advisors's CAH Position: Q1 2026 in Review

AlphaCentric Advisors increased its Cardinal Health (CAH) stake by 44% in Q1 2026, buying an estimated $122K and bringing the position to 1,865 shares worth $394K. The position accounts for 0.39% of the portfolio, ranked #89.

AlphaCentric Advisors first reported a position in CAH in Q2 2020 and has held it in 11 quarters since. The position peaked at $509K in Q4 2023. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • AlphaCentric Advisors held 1,865 shares of Cardinal Health worth $394K as of Q1 2026.
  • AlphaCentric Advisors bought 566 Cardinal Health shares in Q1 2026, an estimated $122K.
  • Cardinal Health made up 0.39% of AlphaCentric Advisors's portfolio in Q1 2026, its #89 holding.
  • AlphaCentric Advisors first reported a position in Cardinal Health in Q2 2020 and has held it in 11 quarters since.
  • AlphaCentric Advisors's Cardinal Health position peaked at $509K in Q4 2023.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.